S5 Ep45: Aggarwal and Girard Analyze Data Amassed With Durvalumab in Unresectable Stage III NSCLC

OncLive® On Air - Een podcast door OncLive® On Air

Probeer Podimo de eerste 30! dagen gratis

Probeer Podimo de eerste 30! dagen gratis

Luister 30 dagen gratis naar exclusieve podcasts en duizenden luisterboeken

 Sponsored
Podcast artwork

Dr. Aggarwal and Dr. Girard discuss the significance of the 5-year survival data from the pivotal PACIFIC trial and the real-world benefit of the study regimen in patients with unresectable stage III NSCLC.

Visit the podcast's native language site